Entries of Arnold, R. on the publication server

Scheibe, F., Alexander, T., Prüss, H., Wengert, O., Harms, L., Angstwurm, K., Hiepe, F., Arnold, R. and Meisel, A. (2016) Devastating humoral CIDP variant remitted by autologous stem cell transplantation. European Journal of Neurology 23 (3), e12-e14. Fulltext not available.

Gratwohl, A., Pfirrmann, M., Zander, A., Kröger, N., Beelen, D., Novotny, J., Nerl, C., Scheid, C., Spiekermann, K., Mayer, J., Sayer, H. G., Falge, C., Bunjes, D., Döhner, H., Ganser, A., Schmidt-Wolf, I., Schwerdtfeger, R., Baurmann, H., Kuse, R., Schmitz, N., Wehmeier, A., Fischer, J. Th., Ho, A. D., Wilhelm, M., Goebeler, M.-E., Lindemann, H. W., Bormann, M., Hertenstein, B., Schlimok, G., Baerlocher, G. M., Aul, C., Pfreundschuh, M., Fabian, M., Staib, P., Edinger, M. , Schatz, M., Fauser, A., Arnold, R., Kindler, T., Wulf, G., Rosselet, A., Hellmann, A., Schäfer, E., Prümmer, O., Schenk, M., Hasford, J., Heimpel, H., Hossfeld, D. K., Kolb, H.-J., Büsche, G., Haferlach, C., Schnittger, S., Müller, M. C., Reiter, A., Berger, U., Saußele, S., Hochhaus, A. and Hehlmann, R. (2016) Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment. Leukemia 30 (3), pp. 562-569. Fulltext not available.

Vrhovac, R., Labopin, M., Ciceri, F., Finke, J., Holler, E., Tischer, J., Lioure, B., Gribben, J., Kanz, L., Blaise, D., Dreger, P., Held, G., Arnold, R., Nagler, A. and Mohty, M. (2016) Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes. Bone Marrow Transplantation 51 (2), pp. 186-193. Fulltext not available.

Stelljes, M., Beelen, D. W., Braess, J., Sauerland, M. C., Heinecke, A., Berning, B., Kolb, H. J., Holler, E., Schwerdtfeger, R., Arnold, R., Spiekermann, K., Muller-Tidow, C., Serve, H. L. , Silling, G., Hiddemann, W., Berdel, W. E., Buchner, T. and Kienast, J. (2011) Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial. Haematologica 96 (7), pp. 972-979. Fulltext not available.

Kienast, Joachim, Beelen, D.W., Kolb, H.J., Schwerdtfeger, R., Arnold, R., Reichle, A., Holler, E., Staib, P., Sauerland, M.C., Berning, B., Schmid, C., Stelljes, M., Berdel, W.E., Hiddemann, W. and Buchner, T. (2007) Allogeneic Hematopoietic Stem Cell Transplantation (Allo-SCT) Versus Conventional Postremission Therapy (PRT) for AML in First Complete Remission (CR1): A Matched Pairs Analysis Based on Data of the AML Cooperative Group (AMLCG) 1999 Trial. Blood 110 (11), p. 328. Fulltext not available.